Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Predictive power of the components of metabolic syndrome in its development: a 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS)

European Journal of Clinical Nutrition volume 64, pages 1207–1214 (2010)Cite this article

Subjects

Abstract

Background/Objectives:

To determine which component of the metabolic syndrome (MetS) is the best predictor of its development.

Subjects/Methods:

In this cohort study, 2279 subjects aged 20–87 years without MetS selected from among the participants of the cross-sectional phase of the Tehran Lipid and Glucose Study (TLGS) were followed up for development of MetS.

Results:

After a mean interval of 6.5 years, 462 and 602 new cases of MetS were diagnosed on the basis of the modified Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria, respectively. The adjusted odds ratio for development of MetS by ATP III criteria was highest for central obesity in men, 2.8 (2.2–3.7), and for triglycerides (TGs) in women, 2.8 (2.0–4.1). The adjusted odds ratio for the development of MetS by IDF criteria was highest for TGs in both men and women: odds ratio 2.8 (2.2–3.7) and 2.9 (1.9–4.3), respectively. A model that included waist circumference (WC) and TGs or WC and high-density lipoprotein (HDL) predicted MetS similar to a model that included all five MetS components.

Conclusion:

Screening for the timely prediction of the development of MetS should include measurement of WC, TGs and plasma HDL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Alberti KG, Zimmet P (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539–553.

    Article  CAS  Google Scholar 

  • Alberti KG, Zimmet P, Shaw J (2005). The metabolic syndrome- a new worldwide definition. Lancet 366, 1059–1062.

    Article  Google Scholar 

  • Anisworth BE, Jacobs DR, Leon AS (1993). Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc 25, 92–98.

    Article  Google Scholar 

  • Azizi F, Rahmani M, Emami H, Madjid M (2000). Tehran Lipid and Glucose Study: rational and design. CVD Prev 3, 242–247.

    Google Scholar 

  • Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A et al. (2002). Determinants of serum HDL-C level in Tehran urban population: Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis 12, 80–89.

    CAS  PubMed  Google Scholar 

  • Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S et al. (2006). Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health 6, 158.

    Article  Google Scholar 

  • Balkau B, Charles MA (1999). Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16, 442–443.

    Article  CAS  Google Scholar 

  • Bloomgarden ZT (2003). American Association of Clinical Endocrinologists (AACE) Consensus Conference on the insulin resistance syndrome. Diabetes Care 26, 933–939.

    Article  Google Scholar 

  • Boyko EJ, Leonetti DL, Bergstrom RW, Newell Morris L, Fujimoto WY (1995). Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans. Diabetes Care 18, 174–181.

    Article  CAS  Google Scholar 

  • Cheung BM, Wat NM, Tam S, Thomas GN, Leung GM, Cheng CH et al. (2008). Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol (Oxf) 68, 730–737.

    Article  CAS  Google Scholar 

  • Davis M (1999). New diagnostic criteria for diabetes: are they doing what they should? Lancet 354, 610–611.

    Article  Google Scholar 

  • DeLong ER, DeLong DM, Clarke-Pearson DL (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837–845.

    Article  CAS  Google Scholar 

  • Esteghamati AR, Gouya MM, Abbasi M, Delavari AR, Alikhani S, Alaedini F et al. (2008). Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care 1, 96–98.

    Article  Google Scholar 

  • Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497.

    Article  Google Scholar 

  • Ford ES (2005). Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care 28, 1769–1778.

    Article  Google Scholar 

  • Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK et al. (2007). Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. Am Coll Cardiol 49, 403–414.

    Article  CAS  Google Scholar 

  • Ghassemi H, Harrison G, Mohammad K (2005). An accelerated nutrition transition in Iran. Public Health Nutr 5, 149–155.

    Google Scholar 

  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, EcKel RH, Franklin BA et al. (2005). Diagnosis and Management of the metabolic syndrome. An American heart Association/National Heart, Lung, and Blood Institute Scientific statement. Circulation 112, 2735–2752.

    Article  Google Scholar 

  • Han TS, Richmond P, Avenell A, Lean ME (1997). Waist circumference reduction and cardiovascular benefits during weight loss in women. Int J Obes Relat Metab Disord 21, 127–134.

    Article  CAS  Google Scholar 

  • Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A (2007). Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord 7, 32.

    Article  CAS  Google Scholar 

  • Janssen I, Katzmarzyk PT, Ross R (2004). Waist circumference and not body mass index explains obesity related health risk. Am J Clin Nutr 79, 379–384.

    Article  CAS  Google Scholar 

  • Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA et al. (2002). Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156, 1070–1077.

    Article  Google Scholar 

  • Lorenzo C, Serrano-Rios M, Martinez-Larrad MT (2003). Central adiposity determines prevalence of the metabolic syndrome. Obes Res 11, 1480–1487.

    Article  Google Scholar 

  • Palaniappan L, Carnethon MR, Wang Y, Hanley AJ, Fortmann SP, Haffner SM et al. (2004). Insulin resistance. Atherosclerosis study predictors of the incident metabolic syndrome in adults: the insulin resistance atherosclerosis study. Diabetes Care 27, 788–793.

    Article  Google Scholar 

  • Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A et al. (1994). Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73, 460–468.

    Article  CAS  Google Scholar 

  • Reaven GM, Lithell H, Landsberg L (1996). Hypertension and associated metabolic abnormalities- the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334, 374–381.

    Article  CAS  Google Scholar 

  • Sheikholeslam R, Mohammad A, Mohammad K, Vaseghi S (2004). Non-communicable disease risk factors in Iran. Asia Pac J Clin Nutr 13 (Suppl), S100.

    Google Scholar 

  • Sheu WH, Chuang SY, Lee WJ, Tsai ST, Chou P, Chen CH et al. (2006). Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan. Diabetes Res Clin Pract 74, 162–168.

    Article  Google Scholar 

  • Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB (2005). Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81, 555–563.

    Article  CAS  Google Scholar 

  • Zabetian A, Hadaegh F, Azizi F (2007). Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 77, 251–257.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by Grant number 121 from the National Research Council of the Islamic Republic of Iran and by the combined support of the National Research Council of Islamic Republic of Iran and Endocrine Research Center of Shahid Beheshti University of Medical Sciences.

Author information

Authors and Affiliations

  1. Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran

    Z Heidari, Y Mehrabi, M Safarkhani & F Azizi

  2. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran

    F Hosseinpanah

Authors
  1. Z Heidari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F Hosseinpanah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Mehrabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Safarkhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Azizi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F Azizi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heidari, Z., Hosseinpanah, F., Mehrabi, Y. et al. Predictive power of the components of metabolic syndrome in its development: a 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS). Eur J Clin Nutr 64, 1207–1214 (2010). https://doi.org/10.1038/ejcn.2010.111

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2010.111

Keywords

This article is cited by

Search

Advanced search

Quick links